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Summary
Copy number variants (CNVs) represent a significant source of
genetic variation in the human genome and have been implicated
in numerous diseases and complex traits. To date, only a few
studies have investigated the role of CNVs in human lifespan. To
investigate the impact of CNVs on prospective mortality at the
extreme end of life, where the genetic component of lifespan
appears most profound, we analyzed genomewide CNV data in
603 Danish nonagenarians and centenarians (mean age
96.9 years, range 90.0–102.5 years). Replication was performed
in 500 long-lived individuals from the Leiden Longevity Study
(mean age 93.2 years, range 88.9–103.4 years). First, we assessed
the association between the CNV burden of each individual (the
number of CNVs, the average CNV length, and the total CNV
length) and mortality and found a significant increase in mortal-
ity per 10 kb increase in the average CNV length, both for all
CNVs (hazard ratio (HR) = 1.024, P = 0.002) and for duplications
(HR = 1.011, P = 0.005), as well as per 100 kb increase in the total
length of deletions (HR = 1.009, P = 0.0005). Next, we assessed
the relation between specific deletions and duplications and
mortality. Although no genome–wide significant associations
were discovered, we identified six deletions and one duplication
that showed consistent association with mortality in both or
either of the sexes across both study populations. These results
indicate that the genome–wide CNV burden, specifically the
average CNV length and the total CNV length, associates with
higher mortality in long-lived individuals.
Key words: aging; copy number variation; deletions; genet-
ics; long-lived individuals; mortality.
Introduction
Human lifespan is a complex trait with a moderate heritability of around
25% (Herskind et al., 1996). So far, only a limited number of loci have
been consistently associated with length of life (Murabito et al., 2012;
Deelen et al., 2014), and hence much of the heritability is still
unaccounted for. This missing heritability might in part be explained
by copy number variants (CNVs) (Manolio et al., 2009).
Copy number variants are defined as DNA segments larger than 1 kb
in size that vary in copy number between individuals due to insertion,
deletion, or duplication (Feuk et al., 2006a). The mechanisms by which
CNVs can affect gene expression and phenotypic traits include alteration
of gene dosage and disruption of coding sequences or regulatory
elements (Feuk et al., 2006b). CNVs have been implicated in numerous
diseases and complex traits, like schizophrenia (International Schizophre-
nia C, 2008), autism (Marshall et al., 2008), and obesity (Wheeler et al.,
2013), but only a few studies have addressed the role of CNVs in survival
and longevity.
The first study of CNVs related to human lifespan was performed by
Kuningas et al. (2011), who prospectively studied 11 442 individuals
with an intake age of 34.0–75.3 years and found that carriers of a
higher burden of common deletions larger than 500 kb had a marginally
increased risk of mortality [hazard ratio (HR) = 1.04] compared to
noncarriers. They also identified two common CNV regions (CNVRs) on
chromosome 11p15.5 and 14q21.3 that associated with higher mortality
at old age. Next, Glessner and colleagues compared CNV frequencies
between 7313 pediatric (aged 0–18 years) and 2701 geriatric individuals
(aged > 67 years, mean age 76 years) with replication in 2079 children
(mean age 8.6 years) and 4692 elderly adults (mean age 60 years). In
total, they identified three deletions and four duplications that were
significantly enriched in the pediatric individuals and that primarily
encompassed genes involved in RNA splicing, suggesting an impact of
this biological mechanism on lifespan (Glessner et al., 2013). Recently,
an analysis of the association between 20 common CNVs not typically
covered by commercial arrays and longevity in 222 senior American
Caucasians with replication in 1283 community-dwelling senior Euro-
pean Caucasians resulted in the identification of a deletion in the
neurexin superfamily member CNTNAP4 on chromosome 16q23.1 that
was inversely associated with survival to 80 years in women (Iakoubov
et al., 2013). Further investigation of CNVs in other gene members of
the neurexin superfamily by the same group additionally led to the
detection of a CNV in the CNTNAP2 gene on chromosome 7q35-36.1
that negatively associated with healthy aging in octogenarian men
(Iakoubov et al., 2015).
None of the studies performed so far have focused on the impact of
CNVs on mortality at the extreme end of life. Here, we explored this by
analyzing the association between the CNV burden of each individual
and prospective mortality, as well as between specific deletions and
duplications and prospective mortality in long-lived individuals of Danish
descent (DKLS, mean age 96.9 years, range 90.0–102.5 years). The
long-lived individuals are all older than 90 years, and they thus represent
the age group where the influence of genetic factors on survival is likely
to be most profound (Hjelmborg et al., 2006). Suggestive findings were
replicated in a second population of long-lived individuals from the
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Leiden Longevity Study (LLS, mean age 93.2 years, range 88.9–
103.4 years), and, in addition, a joint analysis of these findings was
performed.
Results
The characteristics of the discovery study (DKLS) and the replication
study (LLS) populations are summarized in Table 1.
Applying a Bonferroni-corrected significance level of 0.006, the
analysis of the CNV burden of each individual revealed a significant
association between a longer average CNV length and increased
mortality. In the joint analysis including both the DKLS and the LLS,
this was evident for the combined group of CNVs where we detected an
increase in HR of 2.4% per 10 kb increase in the average CNV length
(HR = 1.024, P = 0.002) as well as for duplications only (HR = 1.011,
P = 0.005) (see Table 2). In addition, we observed a significant increase
in mortality as a result of a greater part of the genome being occupied by
deletions with the HR increasing 0.9% per 100 kb increase in the total
length of deletions (HR = 1.009, P = 0.0005).
Altogether, a total of 272 unique deletions and 131 unique
duplications were identified in the DKLS. This distribution of deletions
and duplications is unlikely to reflect the actual distribution of CNVs in
the human genome and rather represents a detection bias associated
with the sensitivity of the CNV detection algorithm used (Zheng et al.,
2012). In the association analysis, none of the CNVs reached statistical
significance after correcting for multiple testing. However, when using a
nominal significance level of P ≤ 0.05, 20 CNVs were found to associate
with mortality (see Table 3), and they were thus selected for replication
in the LLS. In the joint analysis including both study populations, the
association with mortality was consistent for three deletions located on
chromosome 6q14.1 (HR 1.35, 95% CI 1.04–1.74, P = 0.023), 10p13
(HR 1.67, 95% CI 1.05–2.66, P = 0.031), and 13q13.2 (HR 1.43, 95%
CI 1.07–1.91, P = 0.015) and one duplication located on chromosome
9q21.12 (HR 1.55, 95% CI 1.07–2.25, P = 0.021). All of these CNVs
were found to contribute to a higher mortality in carriers compared to
noncarriers. Furthermore, sex-specific analyses (see Table S1 and S2,
Supporting Information) revealed three additional deletions on chromo-
some 1p22.3, 5q31.3, and 8p22 that resulted in higher mortality among
carriers in one of the sexes.
The seven nominally significant CNVs have all, at least partially, been
reported by the Database of Genomic Variants (DGV, http://dgv.tcag.ca/
dgv/app/home; Macdonald et al., 2014), supporting that they represent
true findings. They encompass or are positioned nearby a number of
genes: COL24A1, PCDHA1-PCDHA10, IMPG1, IRAK1BP1, PSD3, TRPM3,
TMEM2, CCDC3, and STARD13 (see Table S3). These genes are
significantly enriched for several Gene Ontology (GO) terms related to
cell adhesion (hemophilic cell adhesion via plasma membrane adhesion
molecules, cell–cell adhesion via plasma membrane adhesion molecules,
cell–cell adhesion, cell adhesion, and biological adhesion) as well as for
the GO term nervous system development. However, when limiting the
contribution of the 10 PCDHA genes by including only one of them in
the enrichment analysis, no GO terms are significantly over- or
underrepresented. In addition to genes, the 5q31.3, 8p22, and
13q13.2 deletions all include CpG islands and regions with indications
of active regulatory elements. The 5q31.3 deletion also contains a
number of eQTLs consisting of single nucleotide polymorphisms (SNPs)
that show association with the expression of the WDR55 and ARL4A
genes, primarily in brain tissue.
Discussion
In this study, we explored the impact of copy number variation on
mortality at the extreme end of life by performing a genome-wide
investigation of the association between CNVs and prospective mortality
in nonagenarians and centenarians.
Table 1 Study population characteristics
Discovery study
(DKLS)
Replication study
(LLS)
N, total 603 500
N, women (%) 453 (75.1%) 302 (60.4%)
Mean age at baseline (range) 96.9 (90.0–102.5) 93.2 (88.9–103.4)
Mean follow-up time (range) 2.9 (0.01–12.9) 4.1 (0.02–11.5)
N, deaths (%) 521 (86.4%) 457 (91.4%)
Table 2 Association between the copy number variant (CNV) burden of each individual and mortality
All CNVs Deletions Duplications
HR (95% CI) P HR (95% CI) P HR (95% CI) P
Number of CNVs* Discovery study (DKLS) 0.991 (0.919–1.068) 0.811 1.049 (0.957–1.150) 0.307 0.917 (0.814–1.034) 0.158
Replication study (LLS) 1.001 (0.928–1.080) 0.997 1.163 (0.959–1.409) 0.124 0.985 (0.912–1.063) 0.697
Joint analysis 0.996 (0.944–1.050) 0.879 1.069 (0.984–1.162) 0.113 0.965 (0.905–1.029) 0.275
Average CNV length† Discovery study (DKLS) 1.025 (1.009–1.041) 0.002 1.015 (1.002–1.027) 0.023 1.011 (1.003–1.020) 0.008
Replication study (LLS) 1.012 (0.963–1.062) 0.644 1.007 (0.980–1.035) 0.598 1.009 (0.977–1.042) 0.597
Joint analysis 1.024 (1.009–1.039) 0.002 1.014 (1.003–1.025) 0.013 1.011 (1.003–1.019) 0.005
Total CNV length‡ Discovery study (DKLS) 1.006 (0.998–1.015) 0.146 1.011 (1.000–1.023) 0.050 1.001 (0.989–1.014) 0.814
Replication study (LLS) 1.004 (0.993–1.015) 0.523 1.009 (1.004–1.014) 0.001 0.999 (0.985–1.014) 0.911
Joint analysis 1.005 (0.999–1.012) 0.107 1.009 (1.004–1.015) 0.0005 1.000 (0.991–1.009) 0.973
HR, hazard ratio; 95% CI, 95% confidence interval; P, P-value obtained from a Cox proportional hazard regression adjusted for study relevant covariates or from the joint
analysis.
The P-value is not adjusted for multiple testing. Joint analysis P-values ≤ 0.006 are shown in bold.
*Results are per additional 10 CNVs.
†Results are per additional 10 kb.
‡Results are per additional 100 kb.
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As our main result, we found that an increase in the average CNV
length significantly associated with a higher mortality, as did an increase
in the total part of the genome occupied by deletions (see Table 2).
These findings are consistent with the results of a previous study in
which the burden of large deletions was found to be associated with
higher mortality (Kuningas et al., 2011), suggesting that longer CNVs,
especially deletions, are more disadvantageous. The identified associa-
tion between a higher CNV burden and increased mortality is generally
in line with the proposed role of genome instability, that is, a decrease in
genome maintenance and hence an accumulation of genomic changes,
in lifespan (Vijg & Suh, 2013) and suggests that even among the very
old, the load of genomic alterations is linked to differences in mortality.
Among the specific deletions and duplications, three deletions on
chromosome 6q14.1, 10p13, and 13q13.2 and one duplication on
chromosome 9q21.12 were consistently associated with higher mortality
across the DKLS and LLS populations (see Table 3), as were a deletion on
chromosome 5q31.3 in women (see Table S1) and two deletions on
chromosome 1p22.3 and 8p22 in men (see Table S2). These seven
nominally significant CNVs are surrounded by numerous genes (see
Table S3), of which two, TRPM3 and STARD13, have previously been
implicated in the regulation of human lifespan (Lunetta et al., 2007;
Yashin et al., 2010). The STARD13 gene has moreover been associated
(P ≤ 1 9 105) with plasma levels of amyloid beta peptides that, among
other things, play a role in Alzheimer’s disease and hypertension
(Chouraki et al., 2014). In addition, also the CCDC3 and IRAK1BP1
genes could be speculated to play a role in human lifespan, as they have
been reported to inhibit inflammation (Conner et al., 2008, 2010; Azad
et al., 2014), and as revealed by the GO enrichment analysis, the
majority of the other genes are involved in cell adhesion, which has
previously been linked to longevity and age-related diseases (Wolfson
et al., 2009; Tian et al., 2013).
In addition to their more direct effect on genes, for example,
alteration of gene dosage and gene disruption, CNVs may also affect
regulatory regions or other functional regions that influence gene
expression, and CNVs have indeed been reported to exert their effect
over distances of more than 6 Mb (Stranger et al., 2007). Only a few of
the seven CNVs found to potentially associate with mortality in long-
lived individuals in this study contain known regulatory elements. The
CNVs harboring these elements additionally overlap or include genes,
and especially the 5q31.3 region, which includes the genes PCDHA1-
PCDHA10, contains a substantial number of CpG islands. The eQTL
analysis revealed that this region also affects the expression of the
WRD55 and ARL4A genes, primarily in brain tissue. Epigenetic changes
in ARL4A have previously been found to associate with maternal
longevity in an epigenome-wide association study of age and age-
related phenotypes (Bell et al., 2012), indicating a possible link between
the 5q31.3 deletion and longevity.
A number of genes known to be of interest for longevity are included
in the CNVs associated with mortality in the DKLS. For instance, a
deletion in WRN is found to be associated with higher mortality. The
WRN gene encodes a RecQ DNA helicase involved in DNA replication and
repair, transcription, and telomere maintenance (Rossi et al., 2010).
Table 3 Association between specific deletions and duplications and mortality
Discovery study (DKLS) Replication study (LLS) Joint analysis
Copy number variant* Locus Type
Size
(kb)
Freq.
(%) HR (95% CI) P
Freq.
(%) HR (95% CI) P HR (95% CI) P
Chr2:18327703-18351537 2p24.2 DUP 23.8 1.3 3.48 (1.62–7.45) 0.001 1.2 0.85 (0.52–1.38) 0.512 1.28 (0.85–1.94) 0.239
Chr9:9516348-9526811 9p23 DUP 10.5 1.0 3.30 (1.45–7.53) 0.005 NA NA NA NA NA
Chr13:32896846-32922331 13q13.1 DEL 25.5 1.3 2.80 (1.30–6.03) 0.009 NA NA NA NA NA
Chr1:80982632-81056073 1p31.1 DUP 73.4 1.0 2.97 (1.29–6.80) 0.010 NA NA NA NA NA
Chr6:55828727-55846527 6p12.1 DEL 17.8 3.3 1.83 (1.14–2.95) 0.012 NA NA NA NA NA
Chr10:13055619-13058458 10p13 DEL 2.8 2.0 2.08 (1.17–3.72) 0.013 1.2 1.15 (0.53–2.47) 0.729 1.67 (1.05–2.66) 0.031
Chr6:29855945-29909559 6p22.1 DEL 53.6 11.8 1.38 (1.06–1.79) 0.015 5.0 0.87 (0.55–1.39) 0.565 1.24 (0.99–1.56) 0.057
Chr9:73902148-73909871 9q21.12 DUP 7.7 1.8 2.05 (1.12–3.75) 0.020 4.0 1.31 (0.81–2.10) 0.272 1.55 (1.07–2.25) 0.021
Chr8:8583109-8589783 8p23.1 DEL 6.7 1.5 2.18 (1.12–4.26) 0.022 1.0 0.93 (0.23–3.75) 0.918 1.87 (1.02–3.43) 0.042
Chr8:30990110-31000860 8p12 DEL 10.8 1.0 2.60 (1.14–5.94) 0.023 NA NA NA NA NA
Chr13:34115595-34143545 13q13.2 DEL 28.0 7.8 1.45 (1.05–2.00) 0.023 2.6 1.32 (0.64–2.70) 0.453 1.43 (1.07–1.91) 0.015
Chr15:102028468-102305129 15q26.3 DUP 276.7 1.0 2.52 (1.12–5.69) 0.026 NA NA NA NA NA
Chr20:36051525-42681088 20q11.23,
20q12,
20q13.11,
20q13.12
DEL 6629.6 1.8 0.45 (0.22–0.91) 0.026 1.0 0.89 (0.47–1.70) 0.729 0.65 (0.40–1.05) 0.079
Chr7:118006251-118070496 7q31.31 DEL 64.2 1.0 2.69 (1.11–6.56) 0.029 NA NA NA NA NA
Chr6:31275246-31285292 6p21.33 DEL 10.0 2.8 1.76 (1.05–2.96) 0.032 2.4 1.02 (0.67–1.56) 0.923 1.27 (0.92–1.74) 0.150
Chr13:88960710-89033066 13q31.2 DEL 72.4 1.0 2.38 (1.06–5.37) 0.036 NA NA NA NA NA
Chr22:18844632-19016663 22q11.21 DUP 172.0 1.3 2.11 (1.04–4.28) 0.039 NA NA NA NA NA
Chr1:161490896-161617516 1q23.3 DUP 126.6 1.8 0.48 (0.23–0.98) 0.043 1.4 2.60 (1.35–5.04) 0.004 1.17 (0.72–1.90) 0.520
Chr6:77439969-77448731 6q14.1 DEL 8.8 6.5 1.42 (1.01–2.00) 0.046 4.4 1.27 (0.88–1.84) 0.194 1.35 (1.04–1.74) 0.023
Chr13:82081150-82087510 13q31.1 DEL 6.4 1.0 2.28 (1.01–5.14) 0.048 NA NA NA NA NA
*Copy number variant (CNV), The discovery study CNV position with information about chromosome and start and stop base pair positions based on the GRCh37/hg19
genome build; Freq., frequency; HR, hazard ratio; 95% CI, 95% confidence interval; P, P-value obtained from a Cox proportional hazard regression adjusted for study
relevant covariates or from the joint analysis.
The P-value is not adjusted for multiple testing. Joint analysis P-values ≤ 0.05 for variants showing the same direction of effect in the discovery and replication studies are
shown in bold. NA, not applicable due to a frequency lower than 1% in the replication study.
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Deleterious mutations in this gene give rise to the premature aging
syndrome Werner, and genetic variation in WRN has previously been
associated with longevity (Soerensen et al., 2012). Also worth high-
lighting are the genes SGK2, which is part of the insulin/insulin-like
growth factor 1 (IGF-1) pathway and has been implicated in human
longevity (Deelen et al., 2013), and BRCA2 that is involved in DNA
double-strand break repair (Jensen, 2013) and has been found to play a
role in the lifespan of mice (Donoho et al., 2003). These CNVs were,
however, not attempted replicated, due to a very low frequency (below
1%) in the LLS sample.
Two studies have recently investigated the potential impact of CNVs
on survival and longevity in a genome-wide manner (Kuningas et al.,
2011; Glessner et al., 2013). We did not find any overlap in results
between our study and the study by Glessner and co-workers. However,
as this study is a case–control study comparing elderly individuals,
primarily in their sixties and seventies, with young individuals under the
age of 19, and as the significantly associated CNVs identified were
enriched only in the pediatric individuals, a lack of overlap could be
expected. In contrast, we saw a minor overlap, although only in sex-
specific analyses, of two CNVs with the study by Kuningas and
colleagues, which is the only other longitudinal study on CNVs and
mortality published so far. The overlapping CNVs are a duplication on
chromosome 14q32.33 and a deletion on chromosome 14q21.2. Due to
the use of a different genome build, the 14q21.2 region is reported as
14q21.3 by Kuningas and co-workers. In both instances, the direction of
effect is the same, that is, for the 14q21.2 deletion HR > 1 and for the
14q32.33 duplication HR < 1, which further supports a role for these
genetic variations in mortality during old age.
There are a number of possible explanations for the modest
agreement between our study and the study by Kuningas and
co-workers. For one, the intake age range of the populations included
in the two studies is different (88.9–103.4 years vs. 34.0–75.3 years,
respectively). This means that while Kuningas and colleagues focus on
mortality from middle age to old age, our study investigates mortality at
very advanced ages. Thus, we explore the possible significance of CNVs
in individuals belonging to the age group where the genetic component
of longevity has been suggested to be most profound and hence more
profound that at younger ages (Hjelmborg et al., 2006). In agreement
with this, it has previously been shown that the association between the
APOE e4 risk allele and mortality increases with higher ages, even after
the age of 100 (Jacobsen et al., 2010). Additionally, the advanced age of
our study population means that a larger part of the individuals included
in our study died during follow-up, which results in a relatively high
number of events and limits the potential bias associated with censoring.
Other parameters affecting the ability to replicate initial findings could
be related to differences in sample size and genetic background, the use
of different platforms and CNV detection algorithms as well as potential
technical and random errors. Compared to the study by Kuningas and
colleagues, our sample size is smaller, and our power to detect CNVs
with lower effect sizes is therefore reduced. However, despite our
smaller sample size, we still detect a higher number of CNVRs (403 vs.
312). Although these numbers are not entirely comparable due to the
use of different methods for defining the CNVRs, this difference is likely
to partly reflect their use of an array containing a lower number of SNPs,
and hence with a lower resolution, than ours.
In conclusion, we found that the genomewide CNV burden,
specifically the average CNV length and the total CNV length, associates
with higher mortality in long-lived individuals. Our results indicate that
CNVs might be important contributors to the genetic component of
human longevity and prompt further investigation.
Experimental procedures
Study populations
Discovery study
The discovery study population, also referred to as the Danish Longevity
Study (DKLS), consisted of participants drawn from the Longitudinal
Study of Danish Centenarians (LSDC), the 1905 Birth Cohort Study, the
1911–12 Birth Cohort Study, the Study of Danish Old Sibs (DOS), and the
Longitudinal Study of Ageing Danish Twins (LSADT). Briefly, the LSDC
and the Danish 1905 Birth Cohort Study are prospective follow-up
studies initiated when participants were 100 and 92 years of age,
respectively (Andersen-Ranberg et al., 2001; Nybo et al., 2001), the
Danish 1911–12 Birth Cohort Study (Robine et al., 2010; Vestergaard
et al. 2015) consists of individuals attaining the age of 100 in the period
from May 5th, 2011 to July 5th, 2012, DOS was initiated in 2004 and
includes families in which at least two siblings were ≥ 90 years of age at
intake, and LSADT was initiated in 1995 and includes Danish twins
≥ 70 years of age (Skytthe et al., 2002).
From DOS and LSADT, one individual from each sib-ship or twin pair
was selected among participants that had reached an age of at least
91 years for DOS and 90 years for LSADT. From the 1905 Birth Cohort
Study, participants were selected among individuals reaching an age of
minimum 96 years. To avoid immortal follow-up time, individuals from
DOS, LSADT, and the 1905 Birth Cohort Study were followed from age
91, 90, and 96 onwards.
Replication study
The replication study population consisted of nonagenarian individuals
from the LLS. In the LLS, long-lived siblings of European descent were
recruited together with their offspring and the spouses of the offspring.
Families were included if at least two long-lived siblings were alive and
fulfilled the age criterion of 89 years or older for men and 91 years or
older for women, representing < 0.5% of the Dutch population in 2001
(Schoenmaker et al., 2006). In total, 944 long-lived proband siblings
(mean age 94 years, range 89–104 years), 1671 offspring (mean age
61 years, range 39–81 years), and 744 offspring partners (mean age
60 years, range 36–79 years) were included. Here, only long-lived
probands (N = 500), who were previously genotyped using Illumina
HumanOmniExpress BeadChips (Illumina Inc., San Diego, CA, USA),
were included.
Vital status was followed until death, January 1st, 2014 (in the DKLS),
or February 1st, 2014 (in the LLS), whichever came first. Information on
survival status was retrieved from the Danish (Pedersen et al., 2006) and
Dutch Central Population Registers.
In the DKLS, permissions to collect blood samples and the use of
register-based data were granted by the Danish National Committee on
Biomedical Research Ethics. The LLS was approved by the Medical Ethical
Committee of the Leiden University Medical Center, and all participants
gave written informed consent.
Genotyping and quality control
In the DKLS, DNA was isolated from whole blood using standard
methods (Miller et al., 1988) and genotyping was carried out according
to the manufacturer’s protocol using the Illumina HumanOmniExpress
BeadChips (Illumina Inc.) (Deelen et al., 2014), which contains 730 525
SNP markers with a median spacing of 2.1 kb and a mean spacing of
4.0 kb.
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Quality control (QC) was performed in Plink (http://pngu.mgh.har-
vard.edu/~purcell/plink/; Purcell et al., 2007) and samples were eval-
uated and excluded based on call rate (call rate < 98.5%),
inconsistencies between genotypic and phenotypic sex, and family
relationships (proportional IBD > 0.1875). Of the 673 originally
included samples, 662 samples remained after the genotype-based
QC.
CNV detection and QC
Copy number variants were detected on autosomes only using the
PennCNV software (Wang et al., 2007). The hidden Markov model
implemented in PennCNV incorporates multiple sources of information,
including the total signal intensity [log R ratio (LRR)] and the allelic
intensity ratio [B allele frequency (BAF)] of each SNP marker, the distance
between the SNPs, and the population frequency of the B allele (PFB) of
SNPs. LRR and BAF values were exported from GenomeStudio (Illumina
Inc.) and the PFB file was compiled from the DKLS samples based on the
BAF of each marker.
After CNV detection, samples with a LRR standard deviation > 0.30
were excluded, as were samples with more than 100 CNVs called and
samples with a GC wave factor above 0.05 or below 0.05. Altogether,
59 samples were excluded, resulting in the inclusion of 603 DKLS
samples in the final analysis.
Copy number variants were excluded if they were < 1 kb in size or
contained < 3 consecutive SNPs indicating a deletion or a duplication.
Generation of CNV datasets
Data on CNV burden, that is, the number of CNVs, the average CNV
length, and the total CNV length, were retrieved for each individual
using Plink (http://pngu.mgh.harvard.edu/~purcell/plink/; Purcell et al.,
2007).
The data on specific deletions and duplications were constructed by
merging CNVs of the same state [either deletion (state 0 or 1) or
duplication (state 3 or 4)] if they overlapped by at least 50% of the
length of the shorter CNV. The outermost boundaries of the merged
regions were used to define the CNVs.
Copy number variants overlapping centromeres or telomeres (as
defined by UCSC (http://genome.ucsc.edu/) using the Table Browser
Software (Karolchik et al., 2004) and the GRCh37/hg19 genome build)
were excluded, as were CNVs with a frequency < 1%.
Replication of CNV associations
Copy number variants of the same state overlapping nominally signif-
icant findings from the discovery study were evaluated for association
with mortality in the LLS individuals (N = 500), who were previously
genotyped using the same SNP array as in the DKLS (Illumina
HumanOmniExpress BeadChips; Illumina Inc.).
DNA from the LLS was isolated from white blood cells using
conventional methods (Beekman et al., 2006). To ensure a high
comparability between the DKLS and the LLS, genotyping and CNV
detection in the LLS were carried out as described for the DKLS with only
minor differences. In the genotype-based QC, samples were excluded
based on a call rate < 95% and no evaluation of family relationships was
performed. For the CNV detection, a standard PFB file (OmniEx-
press_hg19.pfb.new), available on the PennCNV website (http://
www.openbioinformatics.org/penncnv/), was used. In addition, a mod-
ified GC-model file based on hg19 was included.
Statistical analysis
All survival analyses were carried out using the statistical software Stata
(Stata version 13.1; Stata Corporation, College Station, TX, USA) by
applying a left-truncated Cox proportional hazard regression model
adjusted for sex, age at baseline, birth cohort (in the DKLS only), and
familial relations (in the LLS only). The adjustment for birth cohort in the
DKLS was included in order to account for any confounding due to
differences in survival probability between the birth cohorts, which has
been shown to be important in genetic studies (Nygaard et al., 2014).
The adjustment was carried out by including a categorical variable based
on 10-year birth year intervals in the model.
The joint analysis was performed in Plink (http://pngu.mgh.har
vard.edu/~purcell/plink/; Purcell et al., 2007) as a meta-analysis using a
fixed-effect approach. The HRs and the corresponding standard errors
were calculated within each study and combined to obtain a joint
analysis HR and P-value. The 95% confidence intervals of the joint
analysis HRs were calculated using R (http://www.r-project.org/).
In the CNV burden analysis, the association between the number of
CNVs, the average CNV length, and the total CNV length of each
individual and mortality was analyzed for all CNVs as well as for deletions
only and duplications only in the DKLS, in the LLS, and in a joint analysis
including the two populations. Given that the total CNV length is more
or less the product of the number of CNVs and the average CNV length,
that ‘all CNVs’ is made up of deletions and duplications, and that the
joint analysis includes the DKLS and the LLS, a Bonferroni-corrected
significance level of P ≤ 0.006 was applied. This corresponds to the
correction for eight tests, that is, assessing the association between the
number of CNVs and the average CNV length of each individual and
mortality for deletions only and duplications only in the DKLS and in the
LLS.
In the association analysis of specific deletions and duplications and
mortality, a P-value ≤ 1.2 9 104 (0.05/403) was used as the cutoff for
statistical significance. CNVs associated with mortality with a P-value
lower or equal to 0.05 were considered suggestive associations and were
attempted replicated as well as included in the joint analysis.
Gene ontology enrichment analysis and expression
quantitative trait loci (eQTL) analysis
The biological processes associated with the genes encompassed by or
surrounding the CNVs found to suggestively associate with mortality in
the DKLS and the LLS in both genders combined or in women or men
only was assessed using the GO enrichment analysis tool offered by the
GO Consortium (http://geneontology.org/page/go-enrichment-analysis).
The potential effects on gene expression of SNPs in the CNVs
suggestively associated with mortality were examined using the Geno-
type-Tissue Expression (GTEx) eQTL database (http://www.ncbi.nlm.nih.
gov/gtex/GTEX2/gtex.cgi), which is based on expression data of brain
(cerebellum, frontal cortex, temporal cortex, and pons), liver, and
lymphoblastoid cell lines.
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